已收盘 10-09 16:00:00 美东时间
+15.020
+4.25%
今日重点评级关注:HC Wainwright & Co.:上调Cardiff Oncology评级至"买入",目标价9美元;古根海姆:维持Inventiva"买入"评级,目标价从11美元升至14美元
09-16 16:10
JPMorgan analyst Connor Allen finds fintech company Dave Inc‘s (NASDAQ:DAVE) growth and profitability profile “impressive." The Dave Analyst: Allen initiated coverage with an Overweight rating and a price target of $480. The Dave Thesis: Founded in 2015, the company aims to solve the core problem of...
09-15 23:59
今日重点评级关注:富国银行:维持Pyxis Oncology"超配"评级,目标价从12美元升至19美元;Oppenheimer:维持Opus Genetics"跑赢大市"评级,目标价从10美元升至20美元
09-10 15:00
Loop Capital analyst Reginald Smith initiates coverage on Dave (NASDAQ:DAVE) with a Buy rating and announces Price Target of $500.
09-10 05:11
Piper Sandler analyst Patrick Moley initiates coverage on Dave (NASDAQ:DAVE) with a Overweight rating and announces Price Target of $390.
08-17 18:20
今日重点评级关注:Truist Securities:维持AbCellera Biologics"买入"评级,目标价从12美元升至30美元;Stifel:维持Proficient Auto Logistics"买入"评级,目标价从9美元升至12美元
08-12 08:45
今日重点评级关注:康托·菲茨杰拉德:维持EyePoint"超配"评级,目标价从47美元升至55美元;伯恩斯坦:维持Figure Technology"跑赢大市"评级,目标价从67美元升至70美元
08-07 13:41
Citizens analyst Devin Ryan maintains Dave (NASDAQ:DAVE) with a Market Outperform and raises the price target from $450 to $475.
08-06 20:45
SiTime Corporation暴升33.24%;SoundHound AI暴升21.46%;Caris Life Sciences劲升13.37%
08-06 09:01
华盛资讯8月6日讯,Dave Inc公布2026财年Q2业绩,公司Q2营收1.71亿美元,同比增长29.6%,归母净利润0.07亿美元,同比下滑26.0%。
08-06 08:53